OsteoRemedies, Adhezion Biomedical Enter Distribution Agreement

By Julie A. Vetalice

Adhezion Biomedical granted OsteoRemedies exclusive rights to distribute FLORASEAL® Microbial Sealant in the U.S.

The film-forming, cyanoacrylate-based product provides a physical barrier that can remain on the skin for up to seven days, reducing the risk of skin flora contamination throughout a surgical procedure.

OsteoRemedies' portfolio includes the REMEDY® pre-molded modular spacer, UNITE® Antibiotic Bone Cement for 2-stage revision of infected hip, knee and shoulder joints and the OSTEOBOOST® Resorbable Bead Kit, a tri-phasic bone void filler.

Source: OsteoRemedies LLC

Tags: M&A